首页 | 本学科首页   官方微博 | 高级检索  
     


The role of GSTM1, GSTT1, GSTP1, and OGG1 polymorphisms in type 2 diabetes mellitus risk: a case-control study in a Turkish population
Authors:Gönül Nüvit  Kadioglu Ela  Kocabaş Neslihan Aygün  Ozkaya Mesut  Karakaya Ali Esat  Karahalil Bensu
Affiliation:Refik Saydam National Health Public Agency, Toxicology Department, National Poison Center, Ankara, Turkey. nuvitgonul@gmail.com
Abstract:The aim of the present study was to investigate the role of some polymorphisms in GSTs (GSTM1, GSTT1 and GSTP1) which are very important protective mechanisms against oxidative stress and in OGG1 gene which is important in DNA repair, against the risk of type 2 diabetes mellitus (T2DM). 127 T2DM and 127 control subjects were included in the study. DNA was extracted from whole blood. Analyses of GSTM1 and GSTT1 gene polymorphisms were performed by allele specific PCR and those of GSTP1 Ile105Val and OGG1 Ser326Cys by PCR-RFLP. Our data showed that GSTM1 null genotype frequency had a 2-6 times statistically significant increase in a patient group (OR=3.841, 95% CI=2.280-6.469, p<0.001) but no significance with GSTT1 null/positive and GSTP1 Ile105Val genotypes was observed. When T2DM patients with OGG1 Ser326Cys polymorphism were compared with patients with a wild genotype, a 2-3 times statistically significant increase has been observed (OR 1.858, 95% CI=1.099-3.141, p=0.021). The combined effect of GSTM1 null and OGG1 variant genotype frequencies has shown to be statistically significant. Similarly, the risk of T2DM was statistically increased with GSTM1 null (OR=3.841, 95% CI=2.28-6.469), GSTT1 null+GSTP1 (H+M) (OR=4.118, 95% CI=1.327-12.778) and GSTM1 null+OGG1 (H+M) (OR=3.322, 95% CI=1.898-5.816) and GSTT1 null+OGG1 (H+M) (OR=2.179, 95% CI=1.083-4.386) as compared to the control group. According to our study results, it has been observed that the combined evaluation of GSTM1-GSTT1-GSTP1 and OGG1 Ser326Cys gene polymorphisms can be used as candidate genes in the etiology of T2DM, especially in the development of T2DM.
Keywords:BMI, body mass index   DBP, diastolic blood pressure   DM, diabetes mellitus   DNA, deoxyribonucleic acid   GSTs, glutathione S-transferases   GSTT1, glutathione S-transferase theta 1   GSTM1, glutathione S-transferase-mu 1   GSTP1, glutathione S-transferase-pi 1   H, heterozygous   HOMA-R, homeostatic model assessment-insulin resistance index   MBP, mean blood pressure   M, mutant   OR, odds ratio   OGG1, 8-oxoguanine-DNA glycosylase 1 PCR polymerase chain reaction   RFLP, restriction fragment length polymorphism   ROS, reactive oxygen species   SBP, systolic blood pressure   T2DM, type 2 diabetes mellitus   W, wild   WHO, World Health Organization
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号